Making antibody generation rapid, scalable, and democratic through machine learning and continuous evolution
通过机器学习和持续进化,使抗体生成快速、可扩展且民主
基本信息
- 批准号:10474638
- 负责人:
- 金额:$ 168.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-10 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AcetylcholineAffinityAnimalsAntibodiesAntibody AffinityAntibody FormationAntigen TargetingAntigen-Presenting CellsAntigensArchitectureAreaBackBiogenic Amine ReceptorsBiological SciencesBiomedical ResearchCell Surface ReceptorsCellsChemistryClinicCollectionCommunitiesCustomCytometryDataData SetDetergentsDiagnosticDirected Molecular EvolutionDockingDopamineElementsEngineeringEpidemicEpinephrineEvolutionExplosionG-Protein-Coupled ReceptorsGenerationsGenesGeneticHistologyHumanHybridomasImageImmune checkpoint inhibitorImmune systemImmunizationImmunizeImmunoglobulin FragmentsImmunoprecipitationLibrariesMachine LearningMedical ResearchMedicineMethodsModelingMolecularMolecular BiologyMolecular ConformationMonoclonal AntibodiesNeuraxisNeurobiologyNeurosciencesNeurotransmittersNobel PrizeOutcomePathogen detectionPhage DisplayPharmaceutical PreparationsPheromonePlayProblem SolvingProcessProductionProtein EngineeringProteinsProteomePublic HealthReagentResearchResearch PersonnelRoleSignal TransductionSpecificitySpeedSurfaceSystemTechniquesTestingTherapeuticTherapeutic StudiesTrainingTubeUpdateV(D)J RecombinationWestern BlottingYeastsaddictionantibody engineeringantibody librariesantigen bindingbasebiomarker discoverycancer therapycostcrowdsourcingdecision researchdesignempoweredexperimental studyfollow-upimprovedin vivoinnovationinsightinterestmachine learning algorithmmachine learning modelnanobodiesnew technologynovelreceptorresponsescaffoldstructural biologytool
项目摘要
Project Summary/Abstract
It is hard to overstate the importance of monoclonal antibodies in the life sciences. Antibodies are critical tools in biomedical
research and diagnostics (e.g. western blotting, immunoprecipitation, cytometry, biomarker discovery, and histology), are
one of the most rapidly growing class of therapeutics, and are the basis for myriad new strategies in cancer therapy, such as
checkpoint inhibitors that are revolutionizing treatment. Unfortunately, current methods for the generation of custom
antibodies, including animal immunization and phage display, are slow, costly, inaccessible to most researchers, and often
unsuccessful. We propose Autonomously EvolvinG Yeast-displayed antibodieS (AEGYS), a system for the continuous and
rapid evolution of high-quality antibodies against custom antigens that requires only the simple culturing of yeast cells. We
believe this can be achieved by combining cutting-edge generative machine learning algorithms for antibody library design
with a new technology for in vivo continuous evolution and a yeast antigen-presenting cell that we will engineer. If
successful, AEGYS should have a transformative impact across the whole of biomedicine by turning monoclonal antibody
generation into a rapid, scalable, and accessible process where any lab with standard molecular biology capabilities can
generate custom antibodies on demand simply by “immunizing” a test tube of yeast cells with an antigen. We anticipate
that this democratization of antibody generation will also result in an explosion of crowdsourced antibody sequence data
that will train our machine learning algorithms to design better antibody libraries for AEGYS, starting a virtuous cycle. We
ourselves will use AEGYS to generate a panel of subtype- and conformation-specific nanobodies against biogenic amine
receptors including those that respond to acetylcholine, adrenaline, dopamine, and other neurotransmitters, so that we can
understand their role in neurobiology and addiction.!
项目摘要/摘要
单抗在生命科学中的重要性怎么强调都不为过。抗体是生物医学中的重要工具
研究和诊断(例如,免疫印迹、免疫沉淀、细胞学、生物标记物发现和组织学)
是增长最快的治疗学类别之一,是癌症治疗中无数新策略的基础,例如
检查点抑制剂,这是革命性的治疗。不幸的是,当前用于生成定制的方法
抗体,包括动物免疫和噬菌体展示,速度慢,成本高,大多数研究人员无法获得,而且通常
不成功。我们提出了自主进化的酵母展示抗体(AEGYS),这是一个连续和
针对定制抗原的高质量抗体的快速进化,只需要简单地培养酵母细胞。我们
我相信这可以通过结合尖端的生成性机器学习算法来设计抗体库来实现
通过体内持续进化的新技术和我们将设计的酵母抗原提呈细胞。如果
如果成功,AEGYS将通过将单抗转化为单抗,对整个生物医学产生革命性的影响
转化为快速、可扩展和可访问的过程,任何具有标准分子生物学能力的实验室都可以
只需用一种抗原“免疫”酵母细胞的试管,即可按需产生定制抗体。我们期待着
这种抗体产生的民主化也将导致众包抗体序列数据的爆炸性增长
这将训练我们的机器学习算法,为AEGY设计更好的抗体库,开始一个良性循环。我们
我们将使用AEGYS生成一组针对生物胺的亚型和构象特定的纳米体
受体包括那些对乙酰胆碱、肾上腺素、多巴胺和其他神经递质有反应的受体,所以我们可以
了解它们在神经生物学和成瘾中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Kruse其他文献
Andrew Kruse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Kruse', 18)}}的其他基金
Project 1: Structure, function, and inhibition of SEDS-family peptidoglycan polymerases
项目1:SEDS家族肽聚糖聚合酶的结构、功能和抑制
- 批准号:
10699954 - 财政年份:2022
- 资助金额:
$ 168.27万 - 项目类别:
Making antibody generation rapid, scalable, and democratic through machine learning and continuous evolution
通过机器学习和持续进化,使抗体生成快速、可扩展且民主
- 批准号:
10687279 - 财政年份:2020
- 资助金额:
$ 168.27万 - 项目类别:
Making antibody generation rapid, scalable, and democratic through machine learning and continuous evolution
通过机器学习和持续进化,使抗体生成快速、可扩展且民主
- 批准号:
10021311 - 财政年份:2020
- 资助金额:
$ 168.27万 - 项目类别:
Making antibody generation rapid, scalable, and democratic through machine learning and continuous evolution
通过机器学习和持续进化,使抗体生成快速、可扩展且民主
- 批准号:
10260452 - 财政年份:2020
- 资助金额:
$ 168.27万 - 项目类别:
Molecular mechanisms of sigma receptor signaling
西格玛受体信号传导的分子机制
- 批准号:
9236106 - 财政年份:2017
- 资助金额:
$ 168.27万 - 项目类别:
Molecular mechanisms of sigma receptor signaling
西格玛受体信号传导的分子机制
- 批准号:
9906922 - 财政年份:2017
- 资助金额:
$ 168.27万 - 项目类别:
Molecular mechanisms of adiponectin signaling and PAQR function
脂联素信号传导和 PAQR 功能的分子机制
- 批准号:
9349368 - 财政年份:2015
- 资助金额:
$ 168.27万 - 项目类别:
Molecular mechanisms of adiponectin signaling and PAQR function
脂联素信号传导和 PAQR 功能的分子机制
- 批准号:
9144473 - 财政年份:2015
- 资助金额:
$ 168.27万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 168.27万 - 项目类别:
Continuing Grant